Synapsoft logo
AI Insights from Disclosures
Searching...
RPbio Inc. 314140
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
RPbio Inc.'s business fields involve producing and manufacturing pharmaceuticals (cold medicine, analgesics, vitamins, blood circulation improvers, etc.) and health functional foods (eye health, antioxidants, diet, blood circulation improvement, etc.) in various formulations, including soft capsules, and selling them through OEM or ODM methods. In the pharmaceutical segment, the company mainly produces cold medicine and analgesics among over-the-counter drugs, as well as liver medicines and vitamins such as Ursa, a representative soft-capsule product, and also produces prescription drugs such as Gliatamin, South Korea's top-selling dementia prevention drug.
Representative Director Yoon Jaehun
Founded August 5, 2016
Corporation Type KOSDAQ
Industry Classification Manufacture of medicaments
Corporate number 11011-6142668
Business number 620-86-00448
Phone Number 02-2002-9715
Fax Number 02-2002-9849
Website rpskorea.com
Company Address 634 Samseong-ro, Gangnam-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant